Management of substance abuse in the hospital setting

International Anesthesiology Clinics

Volumn 49, Issue 1, 2011, Pages 15-30

  Gist, Richard S ^a   Sullivan, Michael ^a   Serianni, Richard P ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; CHLORDIAZEPOXIDE; CLONIDINE; COCAINE; DIAZEPAM; HALOPERIDOL; LORAZEPAM; METHADONE; METHAMPHETAMINE; NALBUPHINE; OXAZEPAM; PROPOFOL; RISPERIDONE;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG SEEKING BEHAVIOR; HALLUCINATION; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; OPIATE ADDICTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ALCOHOLISM; AMPHETAMINE-RELATED DISORDERS; ANESTHESIOLOGY; COCAINE-RELATED DISORDERS; HOSPITALS; HUMANS; METHAMPHETAMINE; OPIOID-RELATED DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 78751624569     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/AIA.0b013e3181ff4cc0     Document Type: Article

References (35)

1. Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348:1786-1795.
2. Craft PP, Foil MB, Cunningham PR, et al. Intravenous ethanol for alcohol detoxification in trauma patients. South Med J. 1994;87:47-54.
3. Coffin PO, Galea S, Ahern J, et al. Opiates, cocaine, and alcohol combinations in accidental drug overdose deaths in New York City, 1990-1998. Addiction. 2003;98: 739-747.
4. Jeffcoat AR, Perez-Reyes M, Hill JM, et al. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos. 1989;17:153-159.
5. DeMaria S, Bryson EO, Frost EAM. Anesthetic implications of methylene-dioxy-methamphetamine intoxication in a patient with traumatic intracerebral hemorrhage. Middle East J Anesth. 2009;20:281-284.
6. Mihic SJ, Ye Q, Wick MJ, et al. Sites ofalcohol and volatile anaesthetic action of GABA (A) receptors. Nature. 1997;389:385-389.
7. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. Am J Psychiatry. 1995;152:332-340.
8. Hoffman PL, Grant KA, Snell LD, et al. NMDAreceptors: role in ethanol withdrawal seizures. Ann N YAcad Sci. 1992;654:52-69.
9. Tella SR, Schindler CW, Goldberg SR. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J Pharmacol Exp Ther. 1993;267:153-162.
10. Ritz MC, Lamb RJ, Goldberg SR, et al. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987;237:1219-1223.
11. Victor M, Brausch C. The role of abstinence in the genesis of alcoholic epilepsy. Epilepsia. 1967;8:1-20.
12. Victor M, Adams RD. The effect ofalcohol on the nervous system. Res Publ Assoc Res Nerv Ment Dis. 1953;32:526-573.
13. Abraham E, Shoemaker WC, McCartney SF. Cardiorespiratory patterns in severe delirium tremens. Arch Intern Med. 1985;145:1057-1059.
14. DeBellis R, Smith BS, Choi S, et al. Management of delirium tremens. J Intens Care Med. 2005;20:164-173.
15. Koppel B, Samkoff L, Daras M. Relation of cocaine use to seizures and epilepsy. Epilepsia. 1996;37:875-878.
16. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med. 1994;1:330-339.
17. SullivanJT, Sykora K, Schneiderman J, et al. Assessment ofalcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84:1353-1357.
18. Hack JB, Hoffmann RS, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol. 2006;2:55-60.
19. Cagetti E, Liang J, Spigelman I, et al. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABA (A) receptors. Mol Pharmacol. 2003;63:53-64.
20. Darrouj J, Puri N, Prince E, et al. Dexmetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacol Ther. 2008;42: 1703-1705.
21. Kolodgie FD, Wilson PS, Cornhill JF, et al. Increased prevalence of aortic fatty streaks in cholesterol-fed rabbits administered intravenous cocaine: the role of vascular endothelium. Toxicol Pathol. 1993;21:425-435.
22. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345:351-358.
23. Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form ofalkaloidal cocaine. N Engl J Med. 1990;323:699-704.
24. Marzuk PM, Tardiff K, Leon AC, et al. Ambient temperature and mortality from unintentional cocaine overdose. JAMA. 1998;279:1795-1800.
25. World Drug Report, Volume 1: Analysis. United Nations Office on Drugs and Crime. Available online at: www.unodc.org/pdf/WDR-2006/wdr2006-volume1.pdf (Accessed on July 9, 2010).
26. Meredith CW, Jaffe C, Ang-Lee K, et al. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry. 2005;13:141-154.
27. McGregor C, Srisurapanont M, Jittiwutikarn J, et al. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005;100:1320-1329.
28. Turnipseed SD, Richards JR, Kirk JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphe-tamine use. J Emerg Med. 2003;24:369-373.
29. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112.
30. Amato L, Davoli M, Ferri M, et al. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database SystRev. 2002:CD003409.
31. Krantz MJ, Martin J, Stimmel S, et al. QTc interval screening in methadone treatment. Ann Int Med. 2009;150:387-395.
32. Beuger M, Tommasello A, Schwartz R, et al. Clonidine use and abuse among methadone program applicants and patients. J Subst Abuse Treat. 1998;15: 589-593.
33. Buprenorphine: an alternative to methadone. Med Lett Drugs Ther. 2003; 45:13.
34. De Pinto M, Jelacic J, Edwards WT. Very-low-dose ketamine for the management of pain and sedation in the ICU. J Opioid Manag. 2008;4:54-56.
35. Urban MK, Ya Deau JT, Wukovits B, et al. Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. HSS J. 2007;4:62-65.